The international Symposium follows the AgedBrainSYSBIO Second Annual Consortium Meeting
Alzheimer’s disease is characterized by diminishing memory and thinking skills, affecting as many as 8 million Europeans, most over the age of 60. The causes of Alzheimer’s disease are still largely unknown, though they are likely a combination of genetic, environmental and other factors.
As part of ongoing research to better understand the complexities of the human brain, different European-funded FP7-HEALTH consortia such as AgedBrainSYSBIO (on systems biology, synapse and ageing) and SYNSYS (on systems biology and synapse), the European flagship Human Brain Project, Alzheimer's Disease Neuroimaging Initiative (ADNI) and the Allen Institute for Brain Science in the US are embarking on efforts to unravel molecular mechanisms involved in brain functioning both in normal conditions and during ageing.
We expect that this meeting will generate novel interactions between leading groups in the field. Because of the increasing interest in ageing-related diseases such as neuropathologies, we expect the symposium to gather up to 200 participants. This symposium will bring together clinicians, biologists, bioinformaticians, statisticians, who will present the latest advances in the field of neuroscience, taking advantage of state-of-the-art approaches provided by omics-biotechnologies, supercomputers, neuroimaging, amongst others.
ICS’s staff member will attend the meeting ; Guillaume Pavlovic will present a conference.